Candida auris: CDC warns of risk of new, drug resistant strain in USBMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1880 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1880
- Janice Hopkins Tanne
- New York
Outbreaks have been reported in the US of transmissible Candida auris fungal infections that have been found to be resistant to drugs and difficult to treat. In a report published on 22 July the Centers for Disease Control and Prevention said that two clusters of cases had been reported in Washington, DC, and in Texas.1
C auris is a different organism from the “black fungus” reported among covid-19 patients in India.
“These two simultaneous, independent clusters of pan- or echinocandin resistant C auris cases in patients with overlapping inpatient health care exposures and without previous echinocandin use provide the first evidence suggesting that pan- or echinocandin-resistant C auris strains might have been transmitted in US health care settings . …